0000874710 false 0000874710 2022-06-14 2022-06-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)
June 14, 2022

 

ALLIED HEALTHCARE PRODUCTS, INC.
(Exact name of registrant as specified in its charter)

 

Delaware 0-19266 25-1370721
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

 

1720 Sublette Avenue, St. Louis, Missouri
(Address of principal executive offices)
63110
(Zip Code)

 

Registrant’s telephone number, including area code
(314) 771-2400 
 
Not applicable 
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging Growth Company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading Symbol Name of Each Exchange on Which
Registered
Common Stock, $.01 AHPI The NASDAQ Stock Market, LLC

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

As previously reported, the Company is party to a Loan and Security Agreement with North Mill Capital, LLC (“North Mill”), as successor in interest to Summit Financial Resources, L.P., dated effective February 27, 2017, as amended April 16, 2018, April 24, 2019, December 18, 2020 and October 7, 2021 (as amended, the “Credit Agreement”). The Company’s obligations under the Credit Facility are secured by all of the Company’s personal property, both tangible and intangible, pursuant to the terms and subject to the conditions set forth in the Credit Agreement.

 

Effective June 13, 2022, the Company and North Mill amended the Credit Agreement to extend the maturity date to September 30, 2024. Additionally, the following terms of the Credit Agreement have been amended:

 

-The prepayment penalty, which was previously (i) the minimum monthly payment multiplied by (ii) the number of months remaining between February 27, 2022 and the date of such prepayment or termination, has been amended to (i) the minimum monthly payment multiplied by (ii) the number of months remaining between September 30, 2024 and the date of such prepayment or termination.

 

The Company paid a modification few of $5,000.

 

The foregoing summary of the Credit Agreement is qualified in its entirety by reference to the Fifth Amendment to Loan and Security Agreement, a copy of which is filed herewith as Exhibit 99.1, and incorporated by reference herein.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information related to the Credit Agreement discussed under Item 1.01 set forth above is hereby incorporated by reference under this Item 2.03.

 

Item 9.01 Financial Statements and Exhibits.

 

(a)Not applicable.
(b)Not applicable.
(c)Not applicable.
(d)Exhibits.

 

 Exhibit
Number
Description
   
99.1Fifth Amendment to Loan and Security Agreement, dated June 13, 2022, by and between the Allied Healthcare Products, Inc. and North Mill Capital, LLC.
 104Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  ALLIED HEALTHCARE PRODUCTS, INC.
       
  By:    
       
Date:  June 14, 2022   /s/ Daniel C. Dunn  
    Daniel C. Dunn  
    Chief Financial Officer  

 

 

 

Exhibit 99.1

 

Fifth Amendment to Loan and Security Agreement

 

This Fifth Amendment to Loan and Security Agreement (the "Amendment") is made and entered into by and between SUMMIT FINANCIAL RESOURCES, LLC, a Delaware limited liability company and the successor in interest to SUMMIT FINANCIAL RESOURCES, L.P., a Hawaii limited partnership ("Lender"), and ALLIED HEALTHCARE PRODUCTS, INC., a Delaware corporation ("Borrower").

 

Recitals

 

A.            Lender's predecessor in interest and Borrower have entered into a Loan and Security Agreement dated February 27, 2017 (together with any and all exhibits, schedules, addenda or riders hereto, as amended, modified, supplemented, substituted, extended or renewed from time to time, the "Loan and Security Agreement").

 

B.            Lender and Borrower have agreed to further amend the Loan and Security Agreement to extend the Loan Commitment Period from February 27, 2023 to September 30, 2024 and make certain other amendments thereto as set forth herein.

 

Amendment

 

For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Lender and Borrower agree as follows:

 

1.            Definitions. Except as otherwise expressly provided herein, terms assigned defined meanings in the Loan and Security Agreement shall have the same defined meanings in this Amendment. The term "Amendment," as defined in the preamble to this Amendment, is incorporated by reference into the Loan and Security Agreement

 

2.            Modification and Amendment of Loan and Security Agreement. Effective as of the date of this Amendment, the Loan and Security Agreement is amended and modified as follows:

 

a.            The following definition set forth in Section 1 (Definitions) of the Loan and Security Agreement is hereby amended to read as follows:

 

"Loan Commitment Period" means the period from the date of this Loan and Security Agreement to September 30, 2024, and thereafter, successive periods of one (1) year each commencing upon completion of each prior Loan Commitment Period.

 

b.            The first paragraph of Section 3 (Renewal of Loan Commitment Period; Termination of Loan) of the Loan and Security Agreement is hereby amended and restated in its entirety as follows:

 

"3.            Current Loan Commitment Period; Renewal of Loan Commitment Period; Termination of Loan.  The current Loan Commitment Period, which would have otherwise ended on February 27, 2023, in hereby extended to, and shall end on, September 30, 2024.  Each (subsequent) Loan Commitment Period thereafter shall automatically renew for an additional Loan Commitment Period of one (1) year unless Borrower or Lender provides written notice of non-renewal at least sixty (60) days' prior to the end of the then Loan Commitment Period, by registered or certified mail, return receipt requested.  If Borrower elects to terminate the Loan at any time prior September 30, 2024, or an Event of Default accelerates payment of the Loan or terminates the right of Borrower to receive advances hereunder, Borrower shall pay Lender an early termination fee equal to the Monthly Minimum multiplied by the number of months, or portions thereof, remaining until September 30, 2024, which amount shall be due and payable in full upon the date of any such termination; provided, however, in the event Borrower obtains Qualified Bank Financing to replace the Loan, Lender shall waive the foregoing early termination fee so long as Borrower provides at least sixty (60) days' written notice to Lender, by registered or certified mail, return receipt requested, of its intent to replace the Loan with Qualified Bank Financing which notice shall itemize the material financial terms of the Qualified Bank Financing.  Further, notwithstanding the foregoing, so long as no Event of Default exists, in the event Borrower obtains proposed financing from a lender that does not qualify as a Qualified Bank Financing to replace the Loan at any time prior to September 30, 2024, Borrower must provide at least sixty (60) days' written notice to Lender, by registered or certified mail, return receipt requested, of its intent to replace the Loan with such proposed financing, which notice shall itemize the material financial terms of such proposed financing, Lender may, but shall not be obligated to, within thirty (30) days' of Lender's receipt of such notice, provide written notice to Borrower that Lender will match the material financial terms of such proposed financing whereupon Lender and Borrower shall amend the Loan Documents, as necessary, to match the material financial terms of such proposed financing and the Loan Documents shall remain in full force and effect subject to such amendments."

 

Allied Healthcare – Fifth Amendment to Loan and Security Agreement

 

1

 

 

c.            In consideration of Lender's agreement to extend the Loan Commitment Period, Borrower agrees to pay to the Lender a modification fee of Five Thousand Dollars ($5,000) (the "Modification Fee") on the date hereof. The Modification Fee shall include the legal fees of Lender's in-house counsel to prepare this Amendment.

 

3.            Representations and Warranties. Borrower affirms and again makes the representations and warranties set forth in Section 6 (Representations and Warranties) of the Loan and Security Agreement as of the date of this Amendment.

 

4.            Payment of Expenses and Attorneys' Fees. Borrower shall pay all reasonable expenses of Lender related to the negotiation, drafting of documents, and documentation of this Amendment, including, without limitation, the Modification Fee (which shall include all reasonable attorneys' fees and legal expenses, including allocated fees of in-house counsel, in connection with the drafting and revising this Amendment). Lender is authorized and directed to disburse a sufficient amount of funds under the Loan to pay these expenses in full.

 

5.            Loan Documents Remain in Full Force and Effect. Except as expressly amended or modified by this Amendment, the Loan Documents remain in full force and effect. Borrower confirms that the security interests granted by the Loan Documents also secure the Loan and Security Agreement as amended by this Amendment.

 

6.            Borrower Covenants. Borrower covenants with Lender that Borrower shall execute, deliver, and provide to Lender such additional agreements, documents, and instruments as reasonably required by Lender to effectuate the intent of this Amendment.

 

7.            Release. Borrower and its successors and assigns hereby fully, finally, and forever release and discharge Lender and its successors, assigns, directors, officers, employees, agents, and representatives from any and all actions, causes of action, claims, debts, demands, liabilities, obligations, and suits of whatever kind or nature, in law or in equity, that Borrower has or in the future may have, whether known or unknown, in respect of the Loan Documents, the Loan, or the actions or omissions of Lender in respect to the Loan Documents or the Loan and arising from events occurring prior to the date hereof.

 

8.            Authorization. Borrower represents and warrants that the execution, delivery, and performance by Borrower of this Amendment, and all agreements, documents, obligations, and transactions herein contemplated, have been duly authorized by all necessary corporate action on the part of Borrower and are not inconsistent with Borrower's organizational documents or any resolution of the board of directors, members, managers, or other governing body of Borrower and do not and will not contravene any provision of, or constitute a default under, any indenture, mortgage, contract, or other instrument to which Borrower is a party or by which it is bound, and that upon execution and delivery hereof and thereof, this Amendment will constitute legal, valid, and binding agreements and obligations of Borrower, enforceable in accordance with its respective terms.

 

9.            Integrated Agreement; Amendment. This Amendment, together with the Loan and Security Agreement and the other Loan Documents, constitute the entire agreement and understanding between the parties hereto and supersede all other prior and contemporaneous agreements. This Amendment and the Loan and Security Agreement shall be read and interpreted together as one agreement and shall be governed by and construed in accordance with the laws of the State of Utah without regard to its conflict of laws principles. This Amendment shall be deemed to have been executed by the parties hereto in the State of Utah and may not be altered or amended except by written agreement signed by Lender and Borrower. All other prior and contemporaneous agreements, arrangements, and understandings between the parties hereto as to the subject matter hereof are, except as otherwise expressly provided herein, rescinded.

 

Borrower acknowledges and agrees that this Amendment is a final expression of the agreement between Lender and Borrower and this Amendment may not be contradicted by evidence of any alleged oral agreement.

 

[Signatures on Next Page]

 

Allied Healthcare – Fifth Amendment to Loan and Security Agreement

 

2

 

 

Dated: June 13, 2022

 

  SUMMIT FINANCIAL RESOURCES, LLC
     
     
  By: /s/Beatriz Hernandez
  Name: Beatriz Hernandez
  Title: Executive Vice President
     
     
  ALLIED HEALTHCARE PRODUCTS, INC.
     
     
  By: /s/Daniel C. Dunn
  Name: Daniel C. Dunn
  Title: Vice President and CFO

 

Allied Healthcare – Fifth Amendment to Loan and Security Agreement

 

3